Eli Lilly and Company (LLY) reported better-than-expected results on revenue and earnings for the third quarter of 2018 and revised its guidance for full-year 2018. The stock was up over 1.6% in premarket hours on Tuesday. Worldwide revenues grew 7% to $6.06 billion, led by higher volumes and increased demand for new products such as … Continue reading Eli Lilly tops market estimates; revises guidance